Radiation Therapy and Durvalumab With or Without Tremelimumab in Treating Participants With Unresectable, Locally Advanced, or Metastatic Bladder Cancer

NCT03601455 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

13

Enrollment

OTHER

Sponsor class

Conditions

Bladder Urothelial Carcinoma
Stage IV Bladder Cancer AJCC v8
Stage IVA Bladder Cancer AJCC v8
Stage IVB Bladder Cancer AJCC v8

Interventions

BIOLOGICAL: Durvalumab
RADIATION: External Beam Radiation Therapy
BIOLOGICAL: Tremelimumab

Sponsor

Jonsson Comprehensive Cancer Center

Collaborators

[object Object]